|
|
| |
| February
7; 42 (1071) : 11-14 |
| Aggrenox:
A Combination of Antiplatelet Drugs for Stroke Prevention; |
| Epirubicin
for Adjuvant Therapy in Node-Positive Breast Cancer; |
| Sirolimus
(Rapamune) for Transplant Rejection |
| February
21; 42 (1072) : 15-18 |
| Gatifloxacin
and Moxifloxacin: Two New Fluoroquinolones; |
| Phytoestrogens; |
| Aspirin
for Primary Prevention of Cardiovascular Disease |
| |
|
|
|
| |
| April
3; 42 (1075) : 29-32 |
| Calcium
Supplements; |
| Bexarotene
(Targretin) for Cutaneous T-Cell Lymphoma |
| April
17; 42 (1076) : 33-36 |
| Two
New Drugs for Epilepsy; |
| Exemestane
for Advanced Breast Cancer; |
| Substituting
for Troglitazone (Rezulin) |
| |
|
| |
| May
1; 42 (1077) : 37-40 |
Treatment
of Lyme Disease;
(Superseded by issue
1209 - 5/23/05) |
| New
Drugs for Allergic Conjunctivitis |
| May
15; 42 (1078) : 41-44 |
| Dofetilide
for Atrial Fibrillation; |
| Oral
Contraceptives |
| May
29; 42 (1079) : 45-48 |
| Linezolid
(Zyvox); |
| Meloxicam
(Mobic) for Osteoarthritis |
| |
|
| |
| June
12; 42 (1080) : 49-52 |
| AndroGel; |
| Ciclopirox
(Penlac) Nail Lacquer for Onychomycosis; |
| The
Atkins Diet |
| June
26; 42 (1081) : 53-56 |
| Alosetron
(Lotronex) for Treatment of Irritable Bowel Syndrome; |
| Beta-blockers
for Heart Failure; |
| Drug
Interactions with St. John's Wort |
| |
|
|
|
|
|
|
|
| |
| November
13; 42 (1092) : 105-108 |
| Glyburide/Metformin
(Glucovance) for Type 2 Diabetes; |
| Tenecteplase
(TNKase) for Thrombolysis; |
| Docosanol
Cream (Abreva) for Recurrent Herpes Labialis |
| November
27; 42 (1093) : 109-112 |
| Atovaquone/Proguanil
(Malarone) for Malaria; |
| Drugs
That May Cause Cognitive Disorders in the Elderly |
| |
|
| |
| December
11; 42 (1094) : 113-116 |
| Phenylpropanolamine
and Other OTC Alpha-Adrenergic Agonists; |
| Valproate
and Other Anticonvulsants for Psychiatric Disorders; |
| Automated
External Defibrillators |
| |
| |
| |
|
